Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Louise Wilkie - VP, IR and Corporate Communications Alexander D. Macrae - President and CEO D. Mark McClung - EVP and COO Prathyusha Duraibabu - SVP, Principal Accounting Officer and CFO Jason D. Fontenot - SVP and Chief Scientific Officer Nathalie Dubois-Stringfellow - SVP and Chief Development Officer Bettina M. Cockroft - CMO Conference Call Participants Benjamin Burnett - Stifel Grego ...